Skip to main content
ONC logo

BeOne Medicines AG

ONCNASDAQHealthcareBiotechnology

$366.06Today:- (-)1Y +23.30%

As of Oct 27, 2026 close

Market cap
$42.39B
P/E (TTM)
430.95
Forward P/E
-
Dividend yield
-
52-week range
$253.95$385.22
Volume (live)
-
Avg. volume (3M)
390.79K

BeOne Medicines (ONC) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), BeOne Medicines had a P/E ratio of 117.17, return on equity of 7.5% (up from -18.8%), debt-to-equity of 0.46 (up from 0.32) and a current ratio of 3.41 (up from 1.80). A current ratio of 3.41 means current assets exceed current liabilities.

BeOne Medicines Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio117.17-----
Forward P/E66.9576.3776.3776.3776.37-
P/S Ratio6.295.167.6716.1323.6776.06
P/B Ratio7.715.905.335.214.546.07
Price/Tangible Book7.825.995.425.264.586.08
Price/FCF35.70-----
Price/OCF29.82-----
Enterprise Value Ratios
EV/Revenue5.894.726.6913.0520.9361.60
EV/EBITDA54.40-----
EV/EBIT70.42-----
EV/FCF33.44-----
Profitability & Returns
Return on Equity (ROE)7.46%-18.77%-22.26%-38.11%-29.15%-67.19%
Return on Assets (ROA)3.96%-6.06%-12.39%-15.00%-12.72%-28.73%
Return on Invested Capital (ROIC)17.11%-36.89%-138.75%-549.15%--
Return on Capital Employed (ROCE)7.00%-15.30%-30.20%-36.40%-20.70%-36.60%
Leverage & Solvency Ratios
Debt/Equity0.460.320.260.140.110.14
Debt/EBITDA3.28-----
Debt/FCF2.12-----
Liquidity Ratios
Current Ratio3.411.802.323.554.764.61
Quick Ratio2.971.511.973.224.454.40
Efficiency Ratios
Asset Turnover0.760.650.400.190.170.09
Inventory Turnover1.211.301.091.090.9923.18
Yield & Distribution Ratios
Earnings Yield0.85%-3.28%-4.67%-8.77%-5.24%-6.92%
FCF Yield2.80%-3.22%-9.12%-7.98%-5.61%-5.96%
Buyback Yield-7.75%-0.86%-1.22%-11.15%-11.16%-38.99%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BeOne Medicines Financial Ratios

What is BeOne Medicines's P/E ratio?

BeOne Medicines's P/E ratio was 117.17 for fiscal 2025 (period ended Dec 31, 2025).

What is BeOne Medicines's return on equity?

BeOne Medicines's return on equity (ROE) was 7.5% for fiscal 2025 (period ended Dec 31, 2025). It was -18.8% a year earlier.

What is BeOne Medicines's debt-to-equity ratio?

BeOne Medicines's debt-to-equity ratio was 0.46 for fiscal 2025 (period ended Dec 31, 2025). It was 0.32 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition